1. Home
  2. WTI vs ARVN Comparison

WTI vs ARVN Comparison

Compare WTI & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W&T Offshore Inc.

WTI

W&T Offshore Inc.

HOLD

Current Price

$4.10

Market Cap

578.7M

Sector

Energy

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$7.58

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTI
ARVN
Founded
1983
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.7M
658.2M
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
WTI
ARVN
Price
$4.10
$7.58
Analyst Decision
Buy
Buy
Analyst Count
1
19
Target Price
N/A
$15.05
AVG Volume (30 Days)
5.6M
734.6K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
0.89%
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
$487,096,000.00
$262,600,000.00
Revenue This Year
$11.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$6.06
52 Week High
$5.08
$14.22

Technical Indicators

Market Signals
Indicator
WTI
ARVN
Relative Strength Index (RSI) 51.45 36.05
Support Level $3.48 $7.35
Resistance Level $4.49 $8.22
Average True Range (ATR) 0.28 0.39
MACD -0.02 -0.04
Stochastic Oscillator 56.98 29.88

Price Performance

Historical Comparison
WTI
ARVN

About WTI W&T Offshore Inc.

W&T Offshore Inc is an an independent oil, NGL and natural gas producer with all of its operations offshore in the Gulf of America. The company is active in the exploration, development and acquisition of oil and natural gas properties. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion. The company has its operations in Mississippi Canyon; Ewing Bank; Ship Shoal; Garden Banks; and Mobile Bay Complex.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: